相关实验视频
Updated: Jan 15, 2026

10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
3.9K
口腔状细胞癌中的甘油性重编程:分子调节剂和基于天然产品的疗法
1Department of Oral Pathology, College of Dentistry, Dankook University, Cheonan, Republic of Korea.
International dental journal
|October 16, 2025
概括
向有氧糖解,这是口腔状细胞癌 (OSCC) 中的一个关键代谢变化,显示出希望. 自然产品可以通过重新编程瘤微环境和克服抵抗来增强OSCC治疗.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 分子生物学分子生物学
背景情况:
- 口腔状细胞癌 (OSCC) 由于晚期诊断,复发和对治疗的耐药性而带来了重大临床挑战.
- 代谢重编程,特别是增加有氧糖解,是OSCC癌症进展,转移,免疫逃避和治疗失败的标志.
- 这种代谢转变会产生有利于瘤生长的瘤微环境 (TME).
研究的目的:
- 在OSCC中审查糖溶性重编程的分子调节器.
- 探索OSCC瘤微环境的糖性景观,包括与癌症相关的纤维细胞 (CAF),T细胞和与瘤相关的巨细胞 (TAM).
- 突出以天然产品为基础的战略,以有氧糖解为目标,用于OSCC治疗.
主要方法:
- 文献综述综合了OSCC中糖溶性重编程的分子调节器的当前知识.
- 在OSCC TME中分析OSCC TME内的各种细胞组件的糖解特征.
- 评估天然产品作为向有氧糖解的潜在治疗剂.
主要成果:
- 有氧糖解是OSCC进展,转移和治疗耐药性的关键驱动因素.
- OSCC TME 呈现出明显的糖解特征,受CAF,T细胞和TAMs等细胞组件的影响.
- 天然产品显示出在OSCC中准有氧糖解的潜力.
结论:
- 了解糖溶性重编程对于开发OSCC的新型代谢向干预措施至关重要.
- 针对有氧糖解,特别是使用天然产品,可能会提高OSCC现有的化疗和免疫疗法的疗效.
- 基于天然产品的策略有望克服治疗耐药性和重新编程OSCC TME.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

